Comparison of intravenous pracetamol versus ibuprofen for the treatment of child heart disease

Comparison of intravenous pracetamol versus ibuprofen for the treatment of patent ductus arteriosus in preterm infants

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190824044600N1

Enrollment

Registered

2019-09-25

Start date

2018-09-23

Completion date

Unknown

Last updated

2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PDA. Other congenital malformations of other great arteries

Interventions

Intervention 1: Intervention group 1: 30 PDA infants treated with paracetamol. Intervention 2: Intervention group 2: 30 PDA infants treated with Ibuprofen.

Eligibility

Sex/Gender

All

Age

1 Days to 3 Days

Inclusion criteria

Inclusion criteria: PDA diagnosis by a pediatric cardiologist

Exclusion criteria

Exclusion criteria: Other congenital anomalies

Design outcomes

Primary

Measure	Time frame
PDA closure time. Timepoint: Measurement at the begining, day 2, and day 3. Method of measurement: With Echocardiography by Pediatric heart specialist.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNarges Falsafi

Ardabil University of Medical Sciences

meisamfooladi@gmail.com+98 45 3323 0739

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026